Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolli

Showing results (831-840 of 1,466) with videos related to

Pageof 147
Sort By:
Leukemia|June 14, 2018
Multiple myeloma clonal evolution in homogeneously treated patientsJill Corre, Alice Cleynen, Sébastien Robiou du Pont, et al.
The Canadian Journal of Cardiology|December 31, 1997
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoringF H Leenen, T W Wilson, P Bolli, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1979
Therapeutical application of artificial beta-cell in surgery and obstetricsP Brunetti, A Puxeddu, G Calabrese, et al.
Discover Oncology|November 11, 2022
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myelomaDomenica Ronchetti, Vanessa Katia Favasuli, Ilaria Silvestris, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2011
The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammationLuca Piali, Sylvie Froidevaux, Patrick Hess, et al.
Stem Cells (Dayton, Ohio)|August 10, 2016
The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent MechanismJoseph B Moore, John Zhao, Matthew C L Keith, et al.
Circulation|July 25, 2007
Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axisXiaofeng Hu, Shujing Dai, Wen-Jian Wu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 12, 2004
Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotectionJun Zhang, Peipei Ping, Guang-Wu Wang, et al.
Molecular and Cellular Biochemistry|November 16, 2021
Effect of intravenous cell therapy in rats with old myocardial infarctionXian-Liang Tang, Marcin Wysoczynski, Anna M Gumpert, et al.
Langenbeck'S Archives of Surgery|September 16, 2022
Trends in pancreatic surgery in Switzerland: a survey and nationwide analysis over two decadesChristoph Kuemmerli, Marcel André Schneider, Gaëtan-Romain Joliat, et al.
Pageof 147

Showing results (831-840 of 1,466) with videos related to

Sort By:
Pageof 147
Leukemia|June 14, 2018
Multiple myeloma clonal evolution in homogeneously treated patientsJill Corre, Alice Cleynen, Sébastien Robiou du Pont, et al.
The Canadian Journal of Cardiology|December 31, 1997
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoringF H Leenen, T W Wilson, P Bolli, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1979
Therapeutical application of artificial beta-cell in surgery and obstetricsP Brunetti, A Puxeddu, G Calabrese, et al.
Discover Oncology|November 11, 2022
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myelomaDomenica Ronchetti, Vanessa Katia Favasuli, Ilaria Silvestris, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2011
The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammationLuca Piali, Sylvie Froidevaux, Patrick Hess, et al.
Stem Cells (Dayton, Ohio)|August 10, 2016
The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent MechanismJoseph B Moore, John Zhao, Matthew C L Keith, et al.
Circulation|July 25, 2007
Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axisXiaofeng Hu, Shujing Dai, Wen-Jian Wu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 12, 2004
Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotectionJun Zhang, Peipei Ping, Guang-Wu Wang, et al.
Molecular and Cellular Biochemistry|November 16, 2021
Effect of intravenous cell therapy in rats with old myocardial infarctionXian-Liang Tang, Marcin Wysoczynski, Anna M Gumpert, et al.
Langenbeck'S Archives of Surgery|September 16, 2022
Trends in pancreatic surgery in Switzerland: a survey and nationwide analysis over two decadesChristoph Kuemmerli, Marcel André Schneider, Gaëtan-Romain Joliat, et al.
Pageof 147